Skip to main content

BRIEF-Aimmune Therapeutics reports Q1 loss of $0.37 per share

* Fy2016 earnings per share view $-1.68, revenue view $0.00 -- Thomson Reuters I/B/E/S
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.